You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) PROPYLENE GLYCOL MONOPALMITOSTEARATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing PROPYLENE GLYCOL MONOPALMITOSTEARATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing PROPYLENE GLYCOL MONOPALMITOSTEARATE excipient

PROPYLENE GLYCOL MONOPALMITOSTEARATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Propylene Glycol Monopalmitostearate

Introduction to Propylene Glycol Monopalmitostearate

Propylene glycol monopalmitostearate, also known as Monosteolâ„¢, is a lipidic vehicle widely used in pharmaceutical formulations, particularly in topical applications. It serves as a consistency agent and stability-improving agent, preventing phase separation and oil droplet coalescence in formulations[2].

Market Size and Growth Projections

The market for mono propylene glycol, from which propylene glycol monopalmitostearate is derived, is expected to see significant growth over the coming years. Here are some key projections:

  • The global mono propylene glycol market is estimated to be worth USD 3,974 million in 2023 and is projected to reach USD 6,473 million by 2033, growing at a CAGR of 5% during this period[1].
  • Another forecast suggests that the mono propylene glycol market will reach USD 6.99 billion by 2031, growing at a CAGR of 4.6% from 2024 to 2031[4].

Key Market Trends

End-Use Industries

The demand for propylene glycol monopalmitostearate is driven by several end-use industries, including:

  • Pharmaceuticals: It is used as a humectant in topical medications, a preservative in solutions, and a co-solvent in aerosols, parenteral, and oral solutions. The pharmaceutical industry is a significant driver, with substantial demand anticipated for mono propylene glycol due to its versatile applications[3].
  • Cosmetics and Personal Care: The product is also widely used in cosmetics and personal care products, contributing to the overall growth of the market[1].

Geographic Segmentation

The market is geographically segmented, with different regions showing varying growth patterns:

  • North America: Characterized by robust demand from the food and beverage industry and a thriving pharmaceutical sector. The United States is expected to reach a market value of USD 480 million by 2033, growing at a CAGR of 5.1%[1].
  • Asia-Pacific: Rapid industrialization, growing population, and increased urbanization drive demand from diverse sectors such as automotive, construction, and consumer goods. China is anticipated to reach a market value of USD 500 million by 2033, growing at a CAGR of 5.3%[1].
  • Europe: Known for strong regulations regarding health and safety, Europe shows increasing adoption of bio-based mono propylene glycol as sustainable practices gain momentum[4].

Challenges and Opportunities

Environmental Concerns

The conventional method of producing mono propylene glycol from petrochemical sources has negative environmental impacts, including pollution and greenhouse gas emissions. This has led to a growing demand for bio-based alternatives, which, although more expensive, offer a sustainable solution[4].

Price Volatility

Price instability of raw materials, such as propylene oxide, can impact production costs and profitability. This volatility is often caused by changes in crude oil prices and supply chain disruptions[4].

Regulatory Approvals

Strict regulatory approvals, particularly in regions like Europe, can affect the market. However, these regulations also drive the adoption of bio-based mono propylene glycol, presenting an opportunity for growth in the sustainable segment[4].

Key Players and Competitive Landscape

The market for mono propylene glycol and its derivatives, including propylene glycol monopalmitostearate, is dominated by several key players:

  • BASF
  • Shell plc
  • Dow
  • LyondellBasell Industries Holdings B.V.
  • INEOS

These companies are expected to expand production capacity and engage in mergers and acquisitions, which may reshape the competitive landscape over the forecast period[4].

Financial Trajectory

The financial trajectory of the mono propylene glycol market, and by extension the market for propylene glycol monopalmitostearate, is positive:

  • Revenue Growth: The market is expected to grow from USD 3,974 million in 2023 to USD 6,473 million by 2033, indicating a significant revenue increase[1].
  • CAGR: A CAGR of 5% from 2023 to 2033 suggests steady and moderate growth, driven by diverse applications and increasing demand from end-use industries[1].

Bio-Based Alternatives

The adoption of bio-based mono propylene glycol is expected to grow due to sustainability concerns. While bio-based alternatives are more expensive, they offer a viable solution for companies looking to reduce their environmental footprint.

"Environmental sustainability of bio-based mono propylene glycol will be significantly responsible in upholding its demand in the global market over the course of following years."[3]

Conclusion

The market for propylene glycol monopalmitostearate is closely tied to the broader mono propylene glycol market, which is expected to experience significant growth driven by its diverse applications in pharmaceuticals, cosmetics, and other industries. Despite challenges such as price volatility and environmental concerns, the market is poised for steady growth, particularly with the increasing adoption of bio-based alternatives.

Key Takeaways

  • The global mono propylene glycol market is projected to reach USD 6,473 million by 2033, growing at a CAGR of 5%.
  • Propylene glycol monopalmitostearate is a key excipient in pharmaceutical formulations, particularly in topical applications.
  • The pharmaceutical industry is a significant driver of demand for mono propylene glycol.
  • Geographic regions such as North America, Asia-Pacific, and Europe show varying growth patterns driven by local market dynamics and regulatory environments.
  • Bio-based alternatives are gaining traction due to sustainability concerns.

FAQs

What are the primary applications of propylene glycol monopalmitostearate?

Propylene glycol monopalmitostearate is primarily used as a consistency agent and stability-improving agent in topical pharmaceutical formulations.

Which industries drive the demand for mono propylene glycol?

The demand for mono propylene glycol is driven by industries such as pharmaceuticals, cosmetics, and personal care, as well as food and beverage.

What are the environmental concerns associated with mono propylene glycol production?

The conventional production of mono propylene glycol from petrochemical sources has negative environmental impacts, including pollution and greenhouse gas emissions.

How is the adoption of bio-based mono propylene glycol expected to impact the market?

The adoption of bio-based mono propylene glycol is expected to grow due to sustainability concerns, although it may be more expensive than traditional methods.

Which regions are expected to lead the mono propylene glycol market by 2033?

The United States and China are expected to lead the market, with projected values of USD 480 million and USD 500 million, respectively, by 2033.

Sources

  1. Future Market Insights, Mono Propylene Glycol Market Size, Sales Analysis & Opportunity, https://www.futuremarketinsights.com/reports/mono-propylene-glycol-market
  2. Gattefossé, Monosteol™, https://www.gattefosse.com/pharmaceuticals/product-finder/monosteol
  3. GlobeNewswire, Mono Propylene Glycol Market is reaching a valuation of US$ 5,159.5 Million by 2029 - Comprehensive Research Report by FMI, https://www.globenewswire.com/news-release/2022/02/03/2378682/0/en/Mono-Propylene-Glycol-Market-is-reaching-a-valuation-of-US-5-159-5-Million-by-2029-Comprehensive-Research-Report-by-FMI.html
  4. Verified Market Research, Mono Propylene Glycol Market Size, Scope, Trends And Forecast, https://www.verifiedmarketresearch.com/product/mono-propylene-glycol-market/

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.